Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.779077
Title: Development of Aurora A kinase-specific inhibitors as anticancer agents
Author: Bellany, F.
ISNI:       0000 0004 7964 7770
Awarding Body: UCL (University College London)
Current Institution: University College London (University of London)
Date of Award: 2016
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
It is believed that one in two people will be diagnosed with cancer during their lifetime. Therefore, there is an urgent need to research and develop new treatments and one of the recent areas of cancer research has targeted components of mitosis, mainly the mitotic kinases. This research project has focused on the Aurora kinases, a family of serine/threonine kinases which play a central role in chromosome segregation and cell division during mitosis. It has recently been demonstrated that Coenzyme A (CoA) is a highly selective ATP-competitive inhibitor of Aurora A kinase. However, the pharmacokinetic properties of CoA, in particular its poor cell permeability, need improvement. The aim of this PhD is to design and synthesise analogues of CoA that are more "drug-like", whilst conserving the features that lead to the selective inhibition. Three series of compounds have been synthesised during the course of this research. The first, conserved the pantothenamide tail and focused on replacing the adenosine moiety of CoA with a heteroaromatic head group based around VX680 - a known inhibitor of the Aurora kinases. During the synthesis of this series, a problematic key step was optimised using a Design of Experiment (DoE) approach. The second series focused on replacing the pyrophosphate group of CoA with known literature mimics to improve the overall drug likeness of the compound before starting to investigate the structure activity relationship (SAR) around the tail region of CoA. The final series of compounds were synthesised to investigate the possible location of the pantetheine tail within the Aurora A binding site - believed to be important for selectivity towards Aurora A. These analogues conserved the structure of CoA and attached affinity labels to the terminal -SH with the capability of covalently interacting with residues within the active site of the kinase.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.779077  DOI: Not available
Share: